Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
1333-86-4
Name of the chemical
carbon black
Concentration
N/A
General Information
Revision date
2014-12-04
Product name
EverGuard TPO Walkway Pads
Manufacturer Name
GAF
Emergency telephone
800 – 424 – 9300
Icons in SDS
Company Information
company name
GAF
Section 2
SECTION 2: Hazards identification
OSHA As defined in the OSHA Hazard Communication Standard, 29 CFR 1910.1200, the products listed below are considered articles and do not require an SDS. In addition, articles are not included in the scope of the Globally Harmonization System (GHS). As such, the GHS labeling elements are not included on this SDS. All components listed for this product are bound within the product. When handled as intended and under normal conditions of use, there is no evidence that any of the ingredients are released in amounts that pose a significant health risk. Although these products are not subject to the OSHA Standard or GHS labeling elements, GAF would like to disclose as much health and safety information as possible to ensure that this product is handled and used properly. This SDS contains valuable information critical to the safe handling and proper use of the product. This SDS should be retained and be made available for employees and other users of this product. In addition, the recommendations for handling and use of these products should be included in worker training programs. ADDITIONAL HAZARD INDENTIFICATION INFORMATION:
Principle Routes of Exposure
None known under normal use. SIGNS & SYMPTOMS OF EXPOSURE EYES: None SKIN: None INGESTION: None INHALATION: None
Acute Health Hazards
None
Health hazards
None CARCINOGENICITY: Titanium Dioxide is classified as a 2B carcinogen (possibly carcinogenic to humans) by the International Agency for Research on Cancer (IARC). Carbon Black is classified as a 2B carcinogen (possibly carcinogenic to humans) by the International Agency for Research on Cancer (IARC).